ASMS 2025 Press Conference
Launch of timsOmni™, timsMetabo™, proteoElute™ and timsUltra AIP
Bruker, the world leader in manufacturing scientific instruments, announced today breaking news on cutting edge discoveries to its market leading mass spectrometry systems optimized to accelerate scientific research.
To get this exciting news out please find supporting material on the new launches changing the face of mass spectrometry in laboratories focusing on Proteomics through Metabolomics to Imaging and Pharma/BioPharma applications, as well as for industrial and applied analysis.
Press Releases ASMS 2025
Launch Material for timsOmni™, timsMetabo™, timsUltra AIP, proteoElute™
GlycoTyper/GlycoTyper Pharma
- GlycoTyper Page
- LCMS 242 - From Spatial Biology Glycomic Imaging to High Resolution Glycoproteomics: Integrating GlycoPath MALDI-MSI and glyco-PASEF Glycopeptide LC-MS/MS
- MT 146 - N-glycan profiling of biotherapeutic monoclonal antibodies using Bruker’s timsTOF fleX and neofleX platforms and BioPharma Compass Software: a novel tool for smart lead development and selection in pharma-biotech R&D
Further Material
For further information please contact:
Petra Scheffer, Ph.D.
Director Marketing Solutions
Bruker Daltonics
T: +49 (421) 2205–2843
E: petra.scheffer@bruker.com
For Research Use Only. Not for use in clinical diagnostic procedures.